A short review on cardiotonic steroids and their aminoguanidine analogues

Molecules

Volumn 5, Issue 1, 2000, Pages 51-81

  Melero, Concepción P ^a   Medarde, Manuel ^a   San Feliciano, Arturo ^a  

^a UNIVERSITY OF SALAMANCA   (Spain)

Author keywords

Aminoguanidine analogues; Digitalis glycosides analogues; Inotropic activity; Na+,K+ ATPase; Structure activity relationships

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); AMINOGUANIDINE; CALOTROPIN; CARDIOTONIC AGENT; CERBERIN; CHEIROSIDE A; CHEIROTOXIN; CYMARIN; DEACETYLTANGHININ; ECHUJIN; HONGHELOSIDE G; NERIANTIN; NERIIN; NIGRESCIN; ODOROSIDE A; ODOROSIDE B; OLEANDRIN; OUABAIN; PERIPLOCIN; PERIPLOCYMARIN; PLANT GLYCOSIDE; SARMENTOCYMARIN; STEROID; STROPHANTHIDIN; STROPHANTHIDOL; STROPHANTHIN; TANGHININ; THEVETIN; UNCLASSIFIED DRUG; UNINDEXED DRUG; UZARIN;

ANGIOSPERM; APOCYNACEAE; ASCLEPIADACEAE; BRASSICACEAE; CRASSULACEAE; DRUG MECHANISM; INOTROPISM; IRIDACEAE; LEGUME; MEDICINAL PLANT; MORACEAE; RANUNCULACEAE; SANTALACEAE; SCROPHULARIACEAE; SHORT SURVEY; STRUCTURE ACTIVITY RELATION;

EID: 0001874893     PISSN: 14203049     EISSN: None     Source Type: Journal    
DOI: 10.3390/50100051     Document Type: Short Survey

References (162)

1. Withering, W. An Account of the Foxglove and Some of its Medical Uses; M. Swynney: London, 1785.
2. Ferriar, J. An Essay on the Medical Properties of the Digitalis purpurea or foxglove. Sowler and Russell: Manchester, 1799.
3. Haack, E.; Kaiser, F.; Gube, M.; Springler, H. Arzneim. Forsch. 1956, 6, 176-182.
4. Although lactone rings of cardenolides and bufadienolides, γ-crotonolactone and α-pirone, easily react with thiol groups, Michael addition reactions to the butenolide ring of cardenolides have not been observed.
5. Repke, K.R.H.; Schönfeld, W.; Weiland, J.; Megges, R.; Hache, A. In Design of Enzyme Inhibitors as Drugs; Sandler, M.; Smith, H.J., Eds.; Oxford University Press: Oxford, 1989; pp 435-502.
6. Thomas, R.E; Gray, P.; Andrews, J. In Advances in Drug Research; Testa, L.B., Ed.; Academic Press: London, 1990; Vol. 19, pp 313-575.
7. Blaustein, M.P. Rev. Physiol. Biochem. Pharmacol. 1974, 70, 33-82.
8. Skou, J.C. Biochim. Biophys. Acta 1957, 23, 394-401.
9. a) Jorgensen, P.L.; Andersen, J.P. J. Membr. Biol. 1988, 103, 95-120;
10. b) Modyanov, N.; Lutsenko, S.; Chertova, E.; Efremov, R.; Gulyaev, E. Acta Physiol. Scand. 1992, 146, 49-58.
11. Skou, J.C. Ann. N. Y. Acad. Sci. 1982, 402, 169-184.
12. Heijne, G.V.; Gavel, Y. Eur. J. Biochem. 1988, 174, 671-678.
13. Kirley, T.L. J. Biol. Chem. 1989, 264, 7185-7192.
14. Geering, K. FEBS 1991, 285, 189-193.
15. Pedemonte, C.H.; Kaplan, J.H. Biochemistry 1992, 31, 10465-10470.
16. a) Béguin, P.; Wang, X.; Firsov, D.; Puoti, A.; Claeys, D.; Horisberger, J.D.; Geering, K. EMBO J. 1997, 16, 4250-4260;
17. b) Minor, N.T.; Sha, Q.; Nichols, C.G.; Mercer, R.W. Proc. Natl. Acad. Sci USA 1998, 95, 6521-6525.
18. a) Collins, J.H.; Leszyk, J. Biochemistry 1987, 26, 8665-8668;
19. b) Mercer, R.W.; Biemesderfer, D.; Bliss, D.P., Jr.; Collins, J.H.; Forbush, B., III. J. Cell Biol. 1993, 121, 579-586.
20. Cornelius, F.; Skou, J.C. Biochim. Biophys. Acta 1988, 944, 223-232.
21. Scheiner-Bobis, G.; Fahlbusch, K.; Schoner, W. J. Biochem. 1987, 168, 123-131.
22. +-Pump, Part A: Molecular Aspects; Skou, J.C.; Nørby, J.G.; Maunsbach, A.B.; Esmann, M., Eds.; Alan R. Liss: New York, 1988; p 219.
23. a) Skriver, E.; Kaveus, U.; Hebert, H.; Maunsbach, A.B. J. Struct. Biol. 1992, 108, 176-185;
24. b) Chetverin, A.B. FEBS Lett. 1986, 196, 121-125.
25. ext·=4-5 mM.
26. Albers, R.W. Annu. Rev. Biochem. 1967, 36, 727-756.
27. Post, R.L.; Kume, S.; Tobin, T.; Orcutt, T.; Sen, A.K. J. Gen. Physiol. 1969, 54, 306S-326S.
28. Shull, G.E.; Schwartz, A.; Kingrel, J.B. Nature 1985, 316, 691-695.
29. Shamraj, O.I.; Lingrel, J.B. Proc. Natl. Acad. Sci. USA 1994, 91, 12952-12956.
30. Lingrel, J.B.; Orlowski, J.; Shull, M.M.; Price, E.M. Prog. Nucleic Acid Res. Mol. Biol. 1990, 38, 37-89.
31. Shyjan, A.W.; Gottardi, C.; Levenson, R. J. Biol. Chem. 1990, 265, 5166-5169.
32. a) Malik, N.; Canfield, V.A.; Beckers, M.C.; Gros, P.; Levenson, R. J. Biol. Chem. 1996, 271, 22754-22758;
33. b) Yu, C.; Xie, Z.; Askari, A.; Modyanov, N.N. Arch. Biochem. Biophys. 1997, 345, 143-149.
34. Good, P.J.; Richter, K.; Dawid, I.B. Proc. Natl. Acad. Sci. USA 1990, 87, 9088-9092.
35. a) Shull, M.M.; Lingrel, J.B. Proc. Natl. Acad. Sci. USA 1987, 84, 4039-4043;
36. b) Shull, M.M.; Pugh, D.G.; Lingrel, J.B. J. Biol. Chem. 1989, 264, 17532-17543;
37. c) Shull, M.M.; Pugh, D.G.; Lingrel, J.B. Genomics 1990, 6, 451-460;
38. d) Lane, L.K.; Shull, M.M.; Whitmer, K.R.; Lingrel, J.B. Genomics 1989, 5, 445-453;
39. e) Yang, F.T.; Schneider, J.W.; Lindgren, V.; Shull, M.M.; Benz, E., Jr.; Lingrel, J.B.; Francke, U. Genomics 1988, 2, 128-138.
40. Levenson, R. Rev. Physiol. Biochem. Pharmacol. 1994, 123, 1-45.
41. Geering, K. Curr. Op. Nephrol. Hypertens. 1997, 6, 434-439.
42. Thomas, R.E. In Molecular Structure and Biological Activity of Steroids; Bohl, M., Daux, W.L., Eds.; CRC Press: Boca Raton, 1992; pp 399-464.
43. Lee, C.O. Am. J. Physiol. 1985, 249, 367-378.
44. Gillis, R.A.; Quest, J.A. In Cardiac Glycosides; Erdmann, E., Greeff, K., Skou, J.C., Eds.; Steinkopff: Darmstadt, 1986; pp 347-356.
45. Steyn, P.S.; van Heerden, F.R. Nat. Prod. Reports 1988, 15, 397-413.
46. a) Fieser, L.F.; Fieser, M. In Natural Products Related to Phenantrene; Reinold corp: New York, 1949; pp 507-577;
47. b) Sivadijan, J. In Traité de Chimie Organique; Grignard, V.; Dupont, G.; Locquin, R., Eds.; Masson: Paris, 1949; pp 1076-1079.
48. a) Deepak, D.; Srivastava, S.; Khare, N.K.; Khare, A. Fortsch. Chem. Org. Naturst. 1996, 69, 71-155;
49. b) Gaignault, J.C.; Bidet, D. Fitoterapia 1988, 59, 259-315.
50. Imre, Z.; Yurdun, T. Planta Medica 1988, 54, 529-531.
51. Pieri, F.; Arnould-Guerin, M.L.; Sefraoni, E.H. Fitoterapia 1992, 63, 333-336.
52. Cheung, H.T.A.; Nelson, C.J. J. Chem. Soc. Perkin Trans. I 1989, 1563-1570.
53. Gil, R.R.; Lin, L.Z.; Chai, H.B.; Pezzuto, J.M.; Cordell, G.A. J. Nat. Products 1995, 58, 848-856.
54. Umehara, K.; Sumii, N.; Satoh, H.; Miyase, T.; Kuroyagani, M.; Ueno, A. Chem Pharm. Bull. 1995, 43, 1565-1568.
55. Abe, F.; Yamauchi, T. Chem. Pharm. Bull. 1994, 42, 2028-2031.
56. a) Thomas, R.E.; Gray, P.; Andrews, J. In Advances in Drug Research; Testa, L.B., Ed.; Academic Press: London, 1990; Vol. 19, pp 313-575;
57. b) Thomas, R.E. In Burger's Medicinal Chemistry and Drug Discovery, 5th ed.; Wolff, M.E., Ed.; John Wiley&Sons: New York, 1996; Vol. 2, pp 153-261;
58. c) Repke, K.R.H.; Weiland, J.; Megges, R. In Progress in Medicinal Chemistry; Ellis, G.P.; Luscombe, D.K., Eds.; Elsevier: Amsterdam, 1993; Vol. 30, pp 135-202;
59. d) Repke, K.R.H.; Weiland, J.; Megges, R. Angew. Chem. Int. Ed. Engl. 1995, 34, 282-294;
60. e) Bohl, M.; Süssmilch, R. Eur. J. Med. Chem. 1986, 21, 193-198;
61. f) Repke, K.R.H., Weiland, J.; Megges, R.; Schon, R.; J. Enzyme Inhib. 1996, 10, 147-157.
62. a) Schönfeld, W.; Weiland, J.; Lindig, C.; Masnyk, M.; Kabat, M.M.; Kurek, A.; Wicha, J.; Repke, K.R.H. Naunyn-Schmiedeberg's Arch. Pharmacol. 1985, 329, 414-426;
63. b) Repke, K.R.H. Trends Pharmacol. Sci. 1985, 6, 275-278.
64. Burt, S.K.; Mackay, D.; Hagler, A.T. In Computer-Aided Drug Design: Methods and Applications; Perun, T.J.; Propts, C.L., Eds.; Marcel Dekker: New York, 1989; pp 55-91.
65. Schönfeld, W.; Schönfeld, R.; Menke, K.H.; Weiland, J.; Repke, K.R.H. Biochem. Pharmacol. 1986, 35, 3221-3231.
66. Shigei, T.; Tsuru, H.; Saito, Y.; Okada, M. Experientia 1973, 29, 449-450.
67. a) Griffin J.F.; Rohrer, D.C.; Ahmed, K.; From. A.H.L.; Hashimoto, T.; Rathore, H.; Fullerton, D.S. Mol. Pharmacol. 1986, 29, 270-274;
68. b) Hashimoto, T.; Rathore, H.; Satoh, D.; Hong, G.; Griffin, J.F.; From, A.H.L.; Ahmed, K.; Fullerton, D.S. J. Med. Chem. 1986, 29, 997-1003.
69. Gobbini, M.; Benicchio, A.; Marazzi, G.; Padoani, G.; Torri, M.; Melloni, P. Steroids 1996, 61, 572-582.
70. San Feliciano, A.; Medarde, M.; Caballero, E.; Hebrero, B.; Tomé, F. Tetrahedron 1990, 46, 6789-6798.
71. a) Medarde, M.; Caballero, E.; Tomé, F.; Gracia, P.G.; Boya, M.; San Feliciano, A. Synth. Commun. 1995, 25, 1377-1382;
72. b) Medarde, M.; Tomé, F.; López, J.L.; Caballero, E.; Boya, M.; Melero, C.P.; San Feliciano, A. Tetrahedron Lett. 1994, 35, 8683-8686;
73. c) Medarde, M.; Caballero, E.; Melero, C.P.; Tomé, F.; San Feliciano, A. Tetrahedron: Asymmetry 1997, 8, 2075-2077.
74. Melero, C.P. Ph.D. disertation. Universidad de Salamanca, 1999.
75. a) Melero, C.P.; Sevillano, L.G.; Caballero, E.; Tomé, F.; Carrón, R.; Montero, M.J.; San Feliciano, A.; Medarde, M. Bioorg. Med. Chem. Lett. 1998, 8, 3217-3222;
76. b) Sevillano, L.G.; Melero, C.P.; Boya, M.; López, J.L.; Tomé, F.; Caballero, E.; Carrón, R.; Montero, M.J.; Medarde, M.; San Feliciano, A. Bioorg. Med. Chem. 1999 (in press).
77. Smith, P.; Brown, L.; Boutagy, J.; Thomas, R.E. J. Med. Chem. 1982, 25, 1222-1226.
78. Schönfeld, W.; Repke, K.R.H. Quant. Struct.-Act. Relat. 1988, 7, 160-165.
79. a) Kahn, J.B.; Acheson, G.H. J. Pharmacol. Exp. Ther. 1955, 115, 301-318;
80. b) Guzmán, A.; Muchowski, J.M.; Strosberg, A.M.; Sims, J.M. Can J. Chem. 1981, 59, 3241-3247;
81. c) San Feliciano, A.; Medarde, M.; Caballero, C.; Hebrero, M.B.; Tomé, F.; Prieto, P.; Montero, M.J. Eur. J. Med. Chem. 1990, 25, 413-417;
82. d) Medarde, M.; Caballero, E.; Tomé, F.; García, A.; Montero, M.J.; Carrón, R.; San Feliciano, A. Eur. J. Med. Chem. 1993, 28, 887-892.
83. Bohl, M.; Süssmilch, R. Eur. J. Med. Chem., Chim. Ther. 1986, 21, 193-198.
84. Boobbyer, D.N.A.; Goodford, P.J.; McWhinnie, P.M.; Wade, R.C. J. Med. Chem. 1989, 32, 1083-1094.
85. a) Pastelin, G.; Méndez, R. Life Sci. 1983, 32, 1905-1909;
86. b) Staroske, T.; Henning, L.; Welzel, P.; Hofmann, H.J.; Müller, D.; Haüsler, T.; Sheldrick, W.S.; Zillikens, S.; Gretzer, B.; Pusch, H.; Glitsch, H.G. Tetrahedron 1996, 52, 12723-12744.
87. a) Fullerton, D.S.; Yoshioka, K.; Rohrer, D.C.; From, A.H.L.; Ahmed, K. Science 1979, 205, 917-919;
88. b) From, A.H.L.; Fullerton, D.S.; Deffo, T.; Kitatsuji, E.; Rohrer, D.C.; Ahmed, A. J. Mol. Cell. Cardiol. 1984, 16, 835-842.
89. Fullerton, D.S.; Yoshioka, K.; Rohrer, D.C.; From, A.H.L.; Ahmed, K. Mol. Pharmacol. 1980, 17, 43-51.
90. Fullerton, D.S.; Ahmed, K.; From, A.H.L., McParland, R.H.; Rohrer, D.C.; Griffin, J.F. In Molecular Graphics and Drug Design; Burgen, A.S.V.; Roberts, G.C.K.; Tute, M.S., Eds.; Elsevier: Amsterdam, 1986; pp 257-284.
91. Scrocco, E.; Tomasi, J. Adv. Quantum Chem. 1978, 11, 115-194.
92. Theil, F.; Lindig, C.; Repke, K.R.H. J. Prakt. Chem. 1980, 322, 1012-1020.
93. Thomas, R.E.; Boutagy, J.; Gelbart, A. J. Pharm. Exp. Ther. 1974, 191, 219-231.
94. Fullerton, D.S.; Yoshioka, K.; Rohrer, D.C.; From, A.H.L.; Ahmed, K. J. Med. Chem. 1979, 22, 529-533.
95. Akera, T. In Cardiac Glycosydes, Part I, Experimental Pharmacology; Greeff, K., Ed.; Springer: Berlin, 1981; Vol. 56, I, pp 287-336.
96. a) Chiu, F.C.K.; Watson, R.T. J. Med. Chem. 1985, 28, 509-515;
97. b) Yoda, A. Mol. Pharmacol. 1973, 9, 51-60.
98. Fullerton, D.S.; Kihara, M.; Deffo, T.; Kitatsuji, E.; Ahmed, K.; Simat, B.; From, A.H.L.; Rohrer, D.C. J. Med. Chem. 1984, 27, 256-261.
99. Rathore, H.; From, A.H.L.; Ahmed, K.; Fullerton, D.S. J. Med. Chem. 1986, 29, 1945-1952.
100. Brown, L.; Thomas, R.E. Arzneim. Forsch. 1983, 33, 814-817.
101. Randimbivololona, F.; Pellegrin, P.; Lesne, M. J. Pharm. Belg. 1984, 39, 225-232.
102. From, A.H.L.; Fullerton, D.S.; Ahmed, K. Mol. Cell Biochem. 1990, 94, 157-165.
103. Gobbini, M.; Benicchio, A.; Padoani, G.; Torri, M.; Melloni, P. Biorg. Med. Chem. Lett. 1997, 7, 469-472.
104. Kyte, J. J. Biol. Chem. 1972, 247, 7634-7641.
105. Jarreau, F.X.; Koening, J.J. European Patent, 1979, EP 3455.
106. Ippolito, J.A.; Alexander, R.S.; Christianson, D.W. J. Mol. Biol. 1990, 215, 457-471.
107. Hansen, O. Pharmacol. Rev. 1984, 36, 143-163.
108. a) Sakakibara, M.; Uchida, A.O. Biosci. Biotech. Biochemistry 1996, 60, 405-410;
109. b) Sakakibara, M.; Uchida, A.O. Biosci. Biotech. Biochemistry 1996, 60, 411-414;
110. c) LaBella, F.S.; Templeton, J.F. Clin. Exp. Hypertens. 1998, 20, 601-609.
111. a) Kim, R.S.; LaBella, F.S.; Zunza, H.; Zunza, F.; Templeton, J.F. Mol. Pharmacol. 1980, 18, 402-405;
112. b) LaBella, F.S.; Bihler, I.; Templeton J.F.; Kim, R.S.; Hnatowich, M.; Rohrer, D.C. Fed. Proc. 1985, 44, 2806-2811.
113. a) Templeton, J.F.; Ling, Y.; Marat, K.; LaBella, F.S. J. Med. Chem. 1997, 40, 1439-1446;
114. b) Templeton, J.F.; Kumar, V.P.S.; Bose, D.; LaBella, F.S. J. Med. Chem. 1989, 32, 1977-1981;
115. c) Templeton, J.F.; Ling, Y.; Jin, J.; Boehmer, M.A.; Zeglam, T.H.; LaBella, F.S. J. Chem. Soc. Perkin Trans. I 1991, 823-829;
116. d) Templeton, J.F.; Kumar, V.P.S.; Bose, D.; Smyth, D.D.; Kim, R.S.; LaBella, F.S. Can. J. Physio. Pharmacol. 1988, 66, 1420-1424;
117. e) Smyth, D.D.; Templeton, J.F.; Kumar, V.P.S.; Yan, Y.; Widajewicz, W.; LaBella, F.S. Can. J. Physiol Pharmacol. 1992, 70, 723-727;
118. f) Templeton, J.F.; Ling, Y.; Zeglam, T.H.; Marat, K.; LaBella, F.S. J. Chem. Soc. Perkin Trans. I 1992, 2503-2517.
119. Templeton, J.F.; Ling, Y.; Zeglam, T.H.; LaBella, F.S. J. Med. Chem. 1993, 36, 42-45.
120. Annual Drug Data Report; J.R. Prous Science Publishers: Barcelona, 1995; p 912.
121. Maixent, J.M.; Berrebi-Bertrand, I.; Lelièvre, L.G.; Fenard, S. Arzneim. Forsch. 1992, 42, 1301-1305.
122. Swynghedauw, B.; Jarreau, F.X.; Nittemberg, A.; Mouas, C.; Preteseille, M.; Lelièvre, L.G. J. Mol. Cell. Cardiol. 1983, 15 (suppl. 2), 55.
123. Repke, K.R.H.; Weiland, J.; Menke, K.H. J. Enzyme Inhib. 1991, 5, 25-32.
124. Fullerton, D.S.; Kitatsuji, E.; Deffo, T.; Rohrer, D.C.; Ahmed, K.; From. A.H.L. Curr. Top. Membr. Transp. 1983, 19, 257-264.
125. Weiland, J.; Schwabe, K.; Hübler, D.; Schönfeld, W.; Repke, K.R.H. J. Enzyme Inhib. 1987, 2, 31-36.
126. a) Silverstein, M.N.; Petit, R.M.; Solberg, L.M. Am. J. Med. 1992, 92, 69-72;
127. Annual Data Drug Report; J.R. Prous Science Publishers: Barcelona 1995; p 914.
128. th Symposium on Medicinal Chemistry; Edinburgh (United Kingdom), 1998. Communication P.217.
129. Szent-Györgyi, A. Chemical Physiology of Contraction in Body Heart Muscle; Academic Press: New York,1953; pp 79-88.
130. a) Goto, A.; Yamada, N.; Yagi, N.; Yoshioka, M.; Sugimoto, Y. Pharmacol. Rev. 1992, 44, 377-399;
131. Hamlyn, J.M.; Manunta, P. J. Hypertens. 1992, 10, S99-S111;
132. c) Crambert, G.; Balzan, S.; Paci, A.; Decollogne, S.; Montali, U.; Ghione, S.; Lelièvre, L.G. Ann. N.Y. Acad. Sci. 1997, 834, 621-625.
133. Goto, A.; Yamada, K. Curr. Opin. Nephrol. Hypertens. 1998, 7, 189-196.
134. Tymiak, A.A.; Norman, J.A.; Bolgar, M.; Didonato, G.C.; Lee, H.; Parker, W.L.; Lo, L.C.; Berova, N.; Nakanishi, K.; Haber, E.; Haupert, G.T., Jr. Proc. Natl. Acad. Sci. USA 1993, 90, 8189-8193.
135. Hamlyn, J.M.; Blaustein, M.P.; Bova, S.; Ducharme, D.W.; Harris, D.W.; Mandel, F.; Mathews, W.R.; Ludens, J.H. Proc. Natl. Acad. Sci. USA 1991, 88, 6259-6263.
136. De Wardener, H.E. J. Hypertens. 1996, 14, S9-S18.
137. Carilli, C.T.; Berne, M.; Cantley, L.C.; Haupert, G.T. J. Biol. Chem. 1985, 260, 1027-1031.
138. + Pump, Part B: Cellular Aspects; Skou, J.C.; Nørby, J.G.; Maunsbach, A.B.; Esmann, M., Eds.; Alan R. Liss: New York, 1988; pp 297-320.
139. Kelly, R.A.; Smith, T.W. Adv. Pharmacol. 1994, 25, 263-288.
140. Paci, A.; Sakakibara, M.; Del Bene, P.; Uchida, A.O. Ann. N.Y. Acad. Sci. 1997, 834, 637-641.
141. a) Doris, P.A. Miner. Electrolyte Metab. 1996, 22, 303-310;
142. b) Hollenberg, N.K.; Graves, S.W. In Progress in Drug Research; Birkhäuser Verlag: Basil, 1996; Vol. 46, pp 9-42;
143. c) Pidgeon, G.B.; Lewis, L.K.; Yandle, T.G.; Richards, A.M.; Nicholls, M.G. J. Hypertens. 1996, 14, 169-171.
144. Greenhill, J.V.; Lue, P. In Progress in Medicinal Chemistry; Ellis, G.P.; Luscombe, D.K., Eds.; Elsevier: Amsterdam, 1993; Vol. 30, pp 203-326.
145. Greenhill, J.V.; Ismail, M.J.; Edwards, P.N.; Taylor, P.J. J. Chem. Soc. Perkin Trans. II 1985, 1255-1264.
146. a) Bryant, H.U.; Nelson, D.L.; Button, D.; Cole, H.W.; Baez, M.B.; Lucaites, V.L.; Wainscott, D.B.; Whitesitt, C.; Reel, J.; Simon, R.; Koppel, G.A. Life Sci. 1996, 59, 1259-1268;
147. b) Bubner, M.; Kasbohm, K.; Heise, K.H.; Richter, P.H. Pharmazie 1995, 50, 71-72;
148. c) Dorhout, B.; Poortenga, P.J.; Kingma, A.W.; De Hoog, E.; Muskiet, F. Biochim. Biophys. Acta 1998, 1381, 95-103;
149. d) Desideri, N.; Sestili, I.; Piccardoni, P.; Rotondo, S.; Cerletti, C.; Stein, M.L. Arch. Pharm. (Weinheim) 1992, 325, 773-777;
150. e) Diamant, S.; Agranat, I.; Goldblum, A.; Cohen, S.; Atlas, D. Biochem. Pharmacol. 1985, 34, 491-498;
151. f) Doubell, P.C.; Oliver, D.W. Arzneim. Forsch. 1992, 42, 65-69;
152. g) Mukhopadhyay, R.; Kapoor, P.; Madhubala, R. Pharmacol. Res. 1996, 33, 67-70.
153. Ng, Y.C.; Leung, W.Y.; Akera, T. Eur. J. Pharmacol. 1988, 155, 93-99.
154. Thomas, R.E.; Boutagy, J.; Gelbart, A. J. Pharm. Sci. 1974, 63, 1649-1683.
155. a) Lingrel, J.B.; Kuntzweiler, T.; J. Biol. Chem. 1994, 269, 19659-19662;
156. b) Shull, G.E.; Lane, L.K.; Lingrel, J.B. Nature 1986, 321, 429-431.
157. Gelbart, A.; Thomas, R.E. J. Med. Chem. 1978, 21, 284-288.
158. Herber, D.; Herzig, S.; Moosig, F.; Neujahr, H. Pharmazie 1995, 50, 663-667.
159. Thomas, R.E.; Gray, P.; Andrews, J. Adv. Drug Res. 1990, 19, 814-839.
160. a) Cerri, A.; Serra, F.; Ferrari, P.; Folpini, E.; Padoani, G.; Melloni, P. J. Med. Chem. 1997, 40, 3484-3488;
161. b) Schutz, S.; Meyer, K.; Kratzer, H. Arzneim. Forsch. 1969, 19, 69-75.
162. David, P.; Mayan, H.; Cohen, H.; Tal, D.M.; Karlish, S.J. J. Biol. Chem. 1992, 267, 1141-1149.